Indian Firm Halts Sales of Execution Drug to U.S.

ATLANTA A pharmaceutical company in India that supplied a key lethal injection drug to at least one U.S. state and contacted to a half dozen others announced it is no longer selling the drug to American prison officials.
 
Kayem Pharmaceutical was fast becoming a major supplier of sodium thiopental, a sedative in the three-drug lethal injection cocktail that most of the 34 death penalty states use.

Read more

You cannot copy content of this page